NCT05453006Completed
HPV Self-Sampling in Somali Women (Isbaar Project)
Reducing Cervical Cancer Screening Disparities in Somali Immigrant Women Through a Primary Care-based HPV Self-sampling Intervention
Source: ClinicalTrials.gov · Last updated 10 Jul 2025
Brief summary (registry, in English)
This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 3367 (actual)
- First submitted
- 6 Jul 2022
- Start date
- 20 Feb 2023
- Primary completion date
- 19 May 2024
- Lead sponsor
- University of Minnesota
- Diseases
- Cervical cancer
- NCT number
- NCT05453006
What you commit to
- Study type: Interventional
- Participants enrolled: 3367
- From 20 Feb 2023 to the primary completion date, 19 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Ineligible for cervical cancer screening, including having a history of cervical cancer or a hysterectomy without intact cervix
Who the study is looking for
- Identify as a Somali woman
- between ages of 30-65
- eligible for cervical cancer screening
Age in the registry: 30 years to 65 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
Related publications
- Experience with Cervical Cancer Screening and Views on HPV Self-Sampling Among Somali American Women.J Gen Intern Med · 2026 · PMID 41410863
This page is information, not medical advice. Discuss any trial with your doctor.